Canada's medical device and health technologies industry has the opportunity to provide new technology solutions within a growing global market. The Health Technologies (HT) program offers a range of integrated technical and research services that assist Canadian health and medical technology firms with product development through tailored and cost-effective solutions.
The HT program works with partners to offer research and technical services in the following market segments: in vitro diagnostics, in vivo devices, implantable devices, simulation and digital health and medical device certification. By taking on many of the critical functions related to product development, the program enables Canadian medical device developers to accelerate their development cycle and to reach the market faster in order to maintain a competitive advantage.
"NRC researchers are experts in the field, so that took the pressure off me," he says. "They were exceedingly helpful in making their research understandable and applicable to my specific needs."
- CTV Winnipeg – Medical Watch – VR helps patients prepare for surgery
- NRC research officer Catherine Proulx is selected as a Women in tech ambassador (in French only with English subtitles)
- NRC facilities and experts' know-how with respect to bioanalytical micro-nano devices (video)
- How the CAE NeuroVR Surgical Simulator Was Developed and Why
- Canadian innovation in food safety poised to hit commercial market
- Healthcare delivery soaring to new heights with interactive simulation
Collaborate with us
Collaborate with us on strategic research projects to help de-risk your innovative ideas, reduce your start-up costs and accelerate your commercial development timelines.
We offer cost-effective research and technical services in these specific market segments:
Bioanalytical micro-nano devices
Development of rapid, point-of-care diagnostic tests and microdevices incorporating biosensors/biochips, microanalytics and microfluidics.
We can help your company design, demonstrate and fabricate low-cost polymer-based microfluidic devices, taking your project from the proof-of-concept phase all the way to producing high-volume prototype production runs. NRC can use its highly-customizable technology and its unique facilities to help you develop next-generation point-of-care analysis devices that can isolate and identify clinically relevant targets such as DNA, RNA, proteins, or metabolites.
NRC is home to state-of-the-art equipment and proprietary knowledge in the design and fabrication of polymeric micro and nano devices. Using technologies such as hot-embossing nanoimprint lithography and microinjection moulding, we have all the facilities to create fully-functional lab-on-a-chip systems. NRC's specialized and integrated expertise in polymer materials can also help make your single-use microdevices more competitive and affordable.
We offer you expertise in:
- Rapid diagnostics for point-of-care or point-of-use, including proven expertise in the following application areas:
- viral infections
- drug response monitoring
- disease progression monitoring
- pathogen detection such as E.coli, Listeria and Noroviruses
In vivo devices
An integrated approach to the development of cutting-edge diagnostics, sensing and intervention devices.
Our scientists and engineers have extensive experience in RF electronics, magnetic resonance, optical sensing and imaging as well as spectroscopy. Successfully bringing a concept to market in the medical device sector is challenging. It requires in-depth technical and clinical know-how, an understanding of the clinical workflow, regulation and remuneration that govern the usage of the device. We have, on several occasions, designed and developed prototypes and brought them into clinical use in jurisdictions governed by Health Canada and the FDA. We will help you design and navigate a path to the successful commercialisation of your product.
We offer you expertise in:
- RF and optical design
- Applications development
- Preclinical and clinical testing
- Concept evaluation
- Support for regulatory testing and documentation
- Imaging/diagnostic software development
Development of advanced, implantable devices by combining innovative biocompatible materials with design, modelling fabrication and testing services.
At NRC, we understand that developing a new, innovative, implantable device for the healthcare sector and bringing it to market can be a challenging and costly endeavor. We can reduce the time and costs to get your concepts into the marketplace. Drawing from our 15 years of experience in biomedical material research and technology, NRC offers you access to state-of-the-art laboratory and production-scale equipment that can bring your ideas from proof-of-concept to prototype, then through testing and validation.
Our expertise and facilities focus on the development and characterization of:
- Metals, polymers, ceramics and their composites
- Dense or porous structures
- Surface treatments and coatings
We can work with your company on the development, design and testing of:
- Orthopedic implants
- Dental implants
- Cardiovascular devices
Simulation and digital health
Utilizing advanced medical information and communications technologies to develop highly-realistic, affordable, real-time, simulation-based technologies.
From the training of healthcare workers to the development of new medical devices, simulation and digital technology are playing an increasing role in the healthcare industry. Our expertise in simulation and digital health will help your organization address technological needs for products targeting the spectrum of healthcare delivery, training, image diagnostics, surgery, intervention, therapy, rehabilitation, wellness and performance. Our expertise integrates agile and standards-based software development, human-machine interactivity and mobility, enhanced rendering of medical images, tissue biomechanics as well as usability/performance metrics relying on virtual reality, physiological and mannequin simulation.
NRC has a proven track record in the development and deployment of real-time simulation. Our unique physics-based software platform provides increased levels of realism, relying on constitutive first principles, multisensory feedback (vision, touch and sound), ergonomic user interaction, as well as corresponding user-performance metrics for measuring safety, outcome and efficiency.
Our technology and services are leveraged across three laboratories:
- Agile software development
- Human-machine interactivity
- Physiological simulation and biomechanics (Biosafety Confinement Level 2)
Our unique BL2 laboratory facility is fundamental in creating realistic simulations. In this lab we characterize the mechanics of biological tissues, soft materials, implants and instruments to develop and validate our mathematical models.
Through our Health Technologies initiative, we will work with you to develop and validate highly-regulated, traditional medical devices, as well as address your technological needs for products throughout the spectrum of healthcare delivery: training, diagnosis, surgery, intervention, rehabilitation, wellness and performance. By providing you with our technical, R&D and validation services, we can help you get your products to market faster and more cost-effectively.
Are you looking to develop affordable bioanalytical solutions, bring minimally-invasive technologies to market, develop or improve implants, or adopt the latest advances in computer technology in an efficient and timely manner for simulation purposes? We can help! To access our state-of-the-art research facilities or to connect with our experts, please contact:
Jean-François Houle, Director General
Developers of health technologies, medical and implantable devices.